CoSara Diagnostics Seeks CDSCO Nod for 30-Minute Point-of-Care TB PCR Test, Eyes India Launch Before Year-End
CoSara Diagnostics, the Indian joint venture of Co-Diagnostics and Synbiotics, has filed its point-of-care TB PCR test with CDSCO after a 676-sample Indian study showed 97.3% sensitivity and 96% specificity, with results in about 30 minutes via a mobile app.
